0001062993-23-009442.txt : 20230421
0001062993-23-009442.hdr.sgml : 20230421
20230421160250
ACCESSION NUMBER: 0001062993-23-009442
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230419
FILED AS OF DATE: 20230421
DATE AS OF CHANGE: 20230421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nusse Roeland
CENTRAL INDEX KEY: 0001492695
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 23836290
MAIL ADDRESS:
STREET 1: 473 TENNESSEE
CITY: PALO ALTO
STATE: CA
ZIP: 94306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0407
4
2023-04-19
0000842023
BIO-TECHNE Corp
TECH
0001492695
Nusse Roeland
614 MCKINLEY PL N E
MINNEAPOLIS
MN
55413
1
0
0
0
0
Common Stock
2023-04-19
4
G
0
377
0
D
28811
D
Stock Options (Right to Buy)
21.85
2013-10-31
2023-10-30
Common Stock
16000
16000
D
Stock Options (Right to Buy)
22.95
2014-10-30
2024-10-30
Common Stock
16000
16000
D
Stock Options (Right to Buy)
21.84
2016-10-29
2025-10-28
Common Stock
17040
17040
D
Stock Options (Right to Buy)
25.30
2017-10-26
2026-10-27
Common Stock
15940
15940
D
Stock Options (Right to Buy)
31.26
2018-10-25
2027-10-26
Common Stock
12500
12500
D
Stock Options (Right to Buy)
44.96
2019-10-24
2028-10-25
Commo Stock
7592
7592
D
Stock Options (Right to Buy)
50.41
2020-10-24
2029-10-24
Common Stock
8044
8044
D
Stock Options (Right to Buy)
63.92
2021-10-28
2030-10-29
Common Stock
6028
6028
D
Stock Options (Right to Buy)
128.81
2022-10-27
2031-10-28
Common Stock
2532
2532
D
Stock Options (Right to Buy)
73.94
2032-10-27
Common Stock
3460
3460
D
The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders.
On November 28, 2022, the Company completed a four-for-one stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to November 28, 2022 have been adjusted to reflect the four-for-one stock split.
Andrew Nick as Attorney-in-Fact for Roeland Nusse pursuant to Power of Attorney previously filed
2023-04-21